相关实验视频

Updated: May 10, 2026

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

蛋白质氨酸甲基转移酶2的抗抑郁作用涉及神经炎症

Shunfeng Liu¹, Bei Zhang², Haowei Guo²

¹College of Pharmacy, Guilin Medical College, Guilin, 541199, China; Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical College, Guilin, 541199, China.

Neurochemistry international

|April 1, 2024

概括

在海马体中过度表达蛋白质氨酸甲基转移酶 (PRMT) 2通过调节微质和基因素甲基化来显示抗抑郁作用. 这表明PRMT2是抑郁症治疗的潜在治疗标.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
精神病学是一个精神病学.

背景情况:

抑郁症与胰岛素甲基化有关,但蛋白质氨酸甲基转移酶 (PRMT) 2 在这个过程中的作用需要进一步调查.
了解PRMT2在抑郁症中的调节作用对于开发新型治疗策略至关重要.

研究的目的:

为了研究PRMT2过度表达对大鼠模型中类似抑郁症的行为的影响.
阐明海马体内潜在的分子机制,包括微质激活和炎症反应.
评估PRMT2作为抑郁症治疗点的潜力.

主要方法:

林氏病毒介导的PRMT2过度表达和PRMT2抑制剂MS023在患有慢性不可预测轻度压力 (CUMS) 的老鼠中给予.
行为测试来评估类似抑郁症的行为.
西方涂抹以量化PRMT2,H3R8me2a,iNOS和Arg1的表达.
微质和PRMT2.2的免疫光染色
用ELISA测量海马组织中的炎症因素.

主要成果:

在CUMS大鼠中,PRMT2过度表达显著抑制了类似抑郁症的行为.
随着PRMT2过度表达,观察到Arg1和H3R8me2a的上调和iNOS的下调.
PRMT2过度表达减少了激活的微质 (M1表型) 和增加了抗炎因素,促进了M2微质的两极分化.
抑制PRMT2可以逆转抗抑郁药的作用.

结论:

在海马体中PRMT2过度表达通过促进M1到M2微质极化,产生抗抑郁作用.
在抑郁症中,PRMT2调节了基因素甲基化 (H3R8me2a) 和炎症通路 (iNOS,Arg1).
在抑郁症治疗中,PRMT2是一个有前途的治疗标.

关键词:

抑郁症抑郁症抑郁症微质细胞中的微质细胞神经炎症是一种神经炎症.PRMT2 PRMT2 的使用方法

更多相关视频

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy

Published on: December 16, 2021

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

相关概念视频

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...